A mission to send a commercial lander to the moon, set for launch in a couple of days, will bring the fruition of projects that have been in the works for years — including projects that aim to put DNA into cold storage on the final frontier.
Pittsburgh-based Astrobotic’s robotic Peregrine lander is scheduled to begin a circuitous 40-day trip to the moon with liftoff from Cape Canaveral Space Force Station in Florida at 2:18 a.m. ET Jan. 8 (11:18 p.m. PT Jan. 7). NASA TV will stream coverage of the countdown.
It’ll mark the first launch for United Launch Alliance’s next-generation Vulcan Centaur rocket, and the first use of the BE-4 engines built by Jeff Bezos’ Blue Origin space venture for Vulcan’s first-stage booster — coming nearly 10 years after the partnership between ULA and Blue Origin was announced.
A successful touchdown next month would go into the history books as the first soft landing of a commercially built spacecraft on the lunar surface — in fact, the first soft lunar landing of any U.S.-built spacecraft since Apollo 17 in 1972. Among the payloads placed aboard the lander is the Iris mini-rover, which would become the first U.S.-built vehicle to wheel around the moon since the Apollo era.
Several NASA-supported payloads will take measurements at the landing site, around a region known as the Gruithuisen Domes, during a science mission that’s projected to last a couple of weeks. Other payloads include micro-robots from Mexico, an art project called MoonArk, mementos and bits of cryptocurrency.
And then there’s the DNA. Samples of DNA — either contributed by donors or synthesized to contain coded information — will be riding on the Peregrine lander as well as the Vulcan’s Centaur V upper stage.